
==== Front
CNS Neurosci Ther
CNS Neurosci Ther
10.1111/(ISSN)1755-5949
CNS
CNS Neuroscience & Therapeutics
1755-5930
1755-5949
John Wiley and Sons Inc. Hoboken

10.1111/cns.70027
CNS70027
Correction
Correction
Correction to Targeting MS4A4A: A novel pathway to improve immunotherapy responses in glioblastoma
03 9 2024
9 2024
03 9 2024
30 9 10.1111/cns.v30.9 e70027© 2024 The Author(s). CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

10.1111/cns.14791 source-schema-version-number2.0
cover-dateSeptember 2024
details-of-publishers-convertorConverter:WILEY_ML3GV2_TO_JATSPMC version:6.4.8 mode:remove_FC converted:04.09.2024
==== Body
pmcShao G, Cui X, Wang Y, et al. Targeting MS4A4A: a novel pathway to improve immunotherapy responses in glioblastoma. CNS Neurosci Ther. 2024;30:e14791. doi:10.1111/cns.14791

The fund, Liaoning Youth Science Project, has been closed and is no longer in use.

We apologize for this error.

Example
